Piramal Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21

Sales

1,840.67

1,575.34

1,677.75

1,417.20

Operating profit

102.75

-19.29

241.96

155.34

Interest

62.02

48.87

31.18

22.37

Gross profit

156.49

156.15

341.74

225.60

EPS (Rs)

0.33

0.25

2.01

1.05

Other income

115.76

224.31

130.96

92.63

Stock adjustment

-76.64

-16.27

37.68

-67.85

Raw material

683.09

578.73

392.52

611.16

Power and fuel

-

-

-

-

Employee expenses

310.49

270.20

199.18

226.12

Excise

-

-

-

-

Admin and selling expenses

-

-

-

-

Research and development expenses

-

-

-

-

Expenses capitalised

-

-

-

-

Other expenses

820.98

761.97

806.41

492.43

Provisions made

-

-

-

-

Depreciation

101.20

91.89

57.31

73.33

Taxation

11.49

27.09

48.34

32.84

Net profit / loss

43.80

30.21

238.70

104.35

Extra ordinary item

-

-6.96

2.61

-15.08

Prior year adjustments

-

-

-

-

Equity capital

1,322.95

1,193.32

1,185.91

994.60

Equity dividend rate

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

OPM (%)

5.58

-1.22

14.42

10.96

GPM (%)

8.00

8.68

18.89

14.94

NPM (%)

2.24

1.68

13.20

6.91